يعرض 1 - 20 نتائج من 29 نتيجة بحث عن '"стратегия ведения"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 65, № 6 (2020); 12-21 ; Российский вестник перинатологии и педиатрии; Том 65, № 6 (2020); 12-21 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2020-65-6

    وصف الملف: application/pdf

    Relation: https://www.ped-perinatology.ru/jour/article/view/1285/1018; Jalanko H., Holmberg C. Congenital Nephrotic Syndrome. In: Pediatric Nephrology. E.D. Avner, W.E. Harmon, P. Niaudet, N. Yoshikawa, F. Emma, S.L. Goldstein (eds). Springer-Verlag, Berlin Heidelberg, 2016; 1: 753–769. DOI:10.1007/978-3-662-43596-0-78; Preston R., Stuart H.M., Lennon R. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? Pediatr Nephrol 2019; 34(2): 195–210. DOI:10.1007/s00467-017-3838-6; Online Mendelian Inheritance in Man: An online catalog of human genes and genetic disorders Electronic resours. https://omim.org. Ссылка активна на 02.07.2020.; Boyer О., Tory K., Machuca E., Antignac С. Idiopathic Nephrotic Syndrome in Children: Genetic Aspects. In: Pediatric Nephrology. E.D. Avner, W.E. Harmon, P. Niaudet, N. Yoshikawa, F. Emma, S.L. Goldstein (eds). Springer-Verlag, Berlin Heidelberg, 2016; 1: 805–837. DOI:10.1007/978-3-662-43596-0-23; Weber S. Hereditary Nephrotic Syndrome. In: Pediatric Kidney Disease. D.F. Geary, F. Schaefer (eds). Springer-Verlag, Berlin, Heidelberg, 2016; 17. DOI:10.1007/978-3-662-52972-0-17; Kestilla M., Lenkkeri U., Mannikko M., Lamerdin J., McCready P. et al. Positionally cloned gene for a novel glomerular protein nephrin – is mutated in congenital nephrotic syndrome. Mol Cell 1998;1 (4): 575–582.; Jalanko Н., Holmberg C. Congenital nephrotic syndrome. Pediatric Nephrology. In: E.D. Avner, W.E. Harmon, P. Niaudet, N. Yoshikawa (eds). Springer, 2009; 1: 601–619.; Jalanko H. Congenital nephrotic syndrome. Pediatr Nephrol 2009; 24: 2121–2128. DOI:10.1007/s00467-007-0633-9; Kari J., Montini G., Bokenhauer D., Brennan E., Rees L., Trompeter R.S. et al. Clinico-patological correlations of congenital and infantile nephrotic syndrome. Pediatr Nephrol 2014; 29(11): 2173–2180. DOI:10.1007/s00467-014-2856-x; Trautmann A., Bodria M., Ozaltin F., Gheisari A., Melk A. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol 2015; 10(4): 592–600. DOI:10.2215/CJN.06260614; Brady T., Mitra A., Hooks J. Maternal serum alpha-fetoprotein level peak at 19–21weeks gestation and subsequently decline in a NPHS1 sequence variant heterozygote; implications for prenatal diagnosis of congenital nephrosis the of Finnish type. Prenat Diagn 2014; 34: 1–3. DOI:10.1002/pd.4375; Gbadegesin R., Hinkes B., Hoskins B. Mutations in PLCE1 are a major cause of isolated diffuse mesangial sclerosis. Nephrol Dial Transplant 2008; 23(4): 1291–1297. DOI:10.1093/ndt/gfm759; Cil O., Besbas N., Duzova A., Topaloglu R., Peco-Antic A., Korkmaz E., Ozaltin F. Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome. Pediatr Nephrol 2015; 30: 1279–1287. DOI:10.1007/s00467-015-3058-х; Li G.M., Cao Q., Shen Q., Sun L., Zhai Y.H. Gene mutation analysis in 12 Chinese children with congenital nephrotic syndrome. BMC Nephrol 2018; 1: 382. DOI:10.1186/s12882-018-1184-y; Boyer O., Woerner S., Yang F., Oakeley E., Linghu B. et al. LMX1B mutations cause hereditary FSGS without extrarenal involvement. J Am Soc Nephrol 2013; 24:1216–1222. DOI:10.1681/ASN.2013020171; Harita Y., Kitanaka S., Isojima T., Ashida A., Hattori M. Spectrum of LMX1B mutations: from Nail-Patella syndrome to isolated nephropathy. Pediatr Nephrol 2017; 32(10): 1845–1850. DOI:10.1007/s00467-016-3462-x; Andeen N.K., Schleit J., Blosser C.D., Dorschner M.O., Hisama F.M., Smith K.D. LMX1B-Associated Nephropathy With Type III Collagen Deposition in the Glomerular and Tubular Basement Membranes. Am J Kidney Dis 2018; 72(2): 296– 301. DOI:10.1053/j.ajkd.2017.09.02318; Ebarasi L., Ashraf S., Bierzynska A., Gee H.Y., McCarthy H. J., Lovric S., Sadowski C.E. Defects of CRB2 cause steroid-resistaant nephritic syndrome. Am J Hum Genet 2015; 96 (1): 153–161. DOI:10.1016/j.ajhg.2014.11.014.; Dorval G., Kuzmuk V., Gribouval O. TBC1D8B loss-of-function mutations lead to X-linked nephrotic syndrome via defective trafficking pathways. Am J Hum Genet 2019; 104(2): 348–355. DOI:10.1016/j.ajhg.2018.12.016.; Denys P., Malvaux P., Van den Berghe H. Assotion d’un syndrome anatomo-pathologique depseudo hermaphroditisme masculine, d’une tumeur de Wilms, d’une nephropathie parynchymateuse et d’une mosaicisme XX/XY. Arch Fr Pediatr 1967; 24: 729–731.; Drash A., Sherman F., Hartmann W.H., Blizzard R.M. A syndrome of pseudohermaphroditism, Wilms’ tumor, hypertension, and degenerative renal disease. J Pediatr 1970; 76(4): 585–593.; Habib R., Gubler M., Antignac C. Syndrome nephrotique congenital ou infantile avec sclerose mesangiale diffuse. Ann Pediatr 1990; 37(2): 73–77.; Nishi K., Nishi K., Inoguchi T., Kamei K., Hamada R., Hataya H., Ogura M. et al. Detailed clinical manifestations at onset and prognosis of neonatal-onset Denys-Drash syndrome and congenital nephrotic syndrome of the Finnish type. Clin Exp Nephrol 2019; 23(8): 1058–1065. DOI:10.1007/s10157-019-01732-7; Савенкова Н.Д., Папаян А.В. Врожденный и инфантильный нефротический синдром. В кн.: Клиническая нефрология детского возраста. А.В. Папаян, Н.Д. Савенкова (ред.). С-Пб: Левша, 2008; 252–258. [Savenkova N.D., Papayan A.V. Congenital and infantile nephrotic syndrome. In: Clinical nephrology of childhood. A.V. Papayan, N.D. Savenkova (eds). St-P: Levcha, 2008; 252–258. (In Russ.)]; Савенкова Н.Д., Чахалян М.И. Клинико-генетическиe особенности и стратегия терапии наследственного врожденного и инфантильного нефротического синдрома у детей. Нефрология 2019; 23(5): 17–28. [Savenkova N.D., Chakhalian M.I. Clinical-genetic features and strategy treatment Hereditary Congenital and Infantile Nephrotic Syndrome in Children. Nefrologiya 2019; 23(5): 17–28. DOI:10.24884/1561-6274-2019-23-5-17-28. (in Russ.)]; Приходина Л.C., Папиж С.В., Столяревич Е.С., Повилайтите П.Е., Шаталов П.А. Инфантильный нефротический синдром: клинико-морфологическая характеристика, генетическая гетерогенность, исходы. Опыт одного центра. Нефрология и диализ 2019; 21(2): 234–242. [Prihodina L.S., Papizh S.V., Stolyarevich E.S., Povilaitite P.E., Shatalov P.A. Infantile nephrotic syndrome: сliniсal-pathology features, genetic heterogeneity, outcome. Nefrologiya i Dialis 2019;21(2):234–242. DOI:10.28996/2618-9801-2019-2-342-242. (in Russ.)]; Игнатова М.С., Длин В.В. Роль генетики в развитиии детской нефрологии. Российский вестник перинатологии и педиатрии 2015; 60(3): 6–9. [Ignatova M.S., Dlin V.V. Role of genetics in the development of of pediatric nephrology. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2015; 60(3): 6–9. (in Russ.)]; Van De Voorde R., Witte D., Kogan J., Goebel J. Pierson syndrome: a novel cause of congenital nephrotic syndrome. Pediatrics 2006; 118(2): 501–505. DOI:10.1542/peds.2005-3154; Savenkova N., Leviashvili Z., Snezhkova E., Karpova T. Nephropathy with proteinuria, hematuria, pretibial epidermolisis bullosa and neurosensory deafness by mutations CD151 gene in sibs. Pediatr Nephrol 2019; 34(10): 1927–1928. DOI:10.1007/s00467-019-04325-4; Colin E., Cong E.H., Mollet G., Guichet A., Gribouval O., Arrondel C., Boyer O. et al. Loss-of-function mutations in WDR 73 are responsible for microcephaly and steroid resistant nephrotic syndrome: Galloway-Mowat syndrome. Am J Hum Genet 2014;95(6):637–648. DOI:10.1016/j.ajhg.2014.10.011; Hyun H.S., Kim S.H., Park E., Cho M.H., Kang H.G. et al. A familial case of Galloway-Mowat syndrome due to a novel TP53RK mutation: a case report. BMC Med Genet 2018; 19(1): 131. DOI:10.1186/s12881-018-0649-y; Ghoumid J., Petit F., Holder-Espinasse M., Jourdain A.-S., Guerra J., Dieux-Coeslier A. et al. Nail-Patella syndrome: clinical and molecular data in 55 families raisinf the hypothetsis of a genetic heterogeneity. Eur J Hum Genet 2016; 24(1): 44–50. DOI:10.1038/ejhg.2015.77; Janecke A.R., Xu R., Steichen-Gersdorf E., Waldegger S., Entenmann A., Giner T. et al. Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcifications. Hum Mutat 2017; 38(4): 365–372. DOI:10.1002/humu.23192; Lovric S., Goncalves S., Gee, H.Y., Oskouian B., Srinivas H., Choi W.-I. et al. Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency. J Clin Invest 2017; 127: 912–928. DOI:10.1172/JCI89626; Prasad R., Hadjidemetriou I., Maharaj A., Meimaridou E., Buonocore F., Saleem M. et al. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome. J Clin Invest 2017; 127: 942–953. DOI:10.1172/JCI90171; Carney E.F. Genetics: SGPL1 mutations cause a novel SRNS syndrome. Nat Rev Nephrol 2017; 13(4): 191. DOI:10.1038/nrneph.2017.19; Reynods B.C., Pikles C.W., Lambert H.J., Ognjanovic M., Crosier J., Johnson S.A., Tse Y. Dominiciliary administration of intravenous albumin in congenital nephrotic syndrome. Pediatr Nephrol 2015; 30: 2045–2050. DOI:10.1007/s00467-015-3177-4; Dufek S., Holtta T., Trautmann, Ylinen A., Alpay H., Ariceta G .et al. and ESPN Dialysis Working Group. Management of children with congenital nephrotic syndrome: challenging treatment paradigms. Nephrol Dial Transplant 2019; 34(8): 1369–1377. DOI:10.1093/ndt/gfy165; Lau K.K., Chan H.H., Massicotte P., Chan A.K. Thrombotic complications of neonates and children with congenital nephrotic syndrome. Curr Pediatr Rev 2014; 10(3): 169–176. DOI:10.1007/573396309666131209210310; Hamasaki Y., Muramatsu M., Hamada R., Ishikura K., Hataya H., Satou H. et al. Long-term outcome of congenital nephrotic syndrome after kidney transplantation in Japan. Clin Exp Nephrol 2018; 22(3): 719–726. DOI:10.1007/s10157-017-1508-4; Holmberg C., Jalanko H. Congenital nephrotic syndrome and recurrence of proteinuria after renal transplantation. Pediatr Nephrol 2014; 29: 2309–2317. DOI:10.1007/s00467-014-2781-z; Graves R.C., Fine R.N. Kidney retransplantation in children following rejection and recurrent disease. Pediatr Nephrol 2016; 31(12): 2235–2247. DOI:10.1007/s00467-016-3346-0; Hölttä T., Bonthuis M., Hölttä T., Bonthuis M., Van Stralen K.J., Bjerre A. et al. Timing of renal replacement therapy does not influence survival and growth in children with congenital nephrotic syndrome caused by mutations in NPHS1: data from the ESPN/ERA-EDTA Registry. Pediatr Nephrol 2016; 31(12): 2317–2325. DOI: org/10.1007/s00467-016-3517-z; Ashoor I.F., Dharnidharka V.R. Non-Immunologic allograft loss in pediatric kidney transplant recipients. Pediatr Nephrol 2019; 34: 211–222. DOI:10.1007/s00467-018-3908-4; Постановление правительства Российской Федерации от 10 декабря 2018 года №1506 «О Программе государственных гарантий бесплатного оказания гражданам медицинской помощи на 2019 год и на плановый период 2020 и 2021 годов». https://www.garant.ru/products/ipo/prime/doc/72023058/. [Decree of the Government of the Russian Federation of December 10, 2018 No. 1506 «On the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2019 and for the Planning Period of 2020 and 2021» https://www.garant.ru/products/ipo/prime/doc/72023058. (in Russ.)]; https://www.ped-perinatology.ru/jour/article/view/1285

  2. 2
  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المصدر: Siberian Journal of Clinical and Experimental Medicine; Том 29, № 3 (2014); 12-18 ; Сибирский журнал клинической и экспериментальной медицины; Том 29, № 3 (2014); 12-18 ; 2713-265X ; 2713-2927 ; 10.29001/2073-8552-2014-29-3

    وصف الملف: application/pdf

    Relation: https://www.sibjcem.ru/jour/article/view/93/94; Болезни сердца и сосудов. Руководство Европейского общества кардиологов / под ред. А.Д. Кэмма, Т.Ф. Люшера, П.В. Серриуса; пер. с англ. под ред. Е.В. Шляхто. - М.: ГЭОТАР-Медиа, 2011. - 1480 с.; Вечерский Ю.Ю., Шипулин В.М. Современные направления хирургической реваскуляризации миокарда // Сибирский медицинский журнал (Томск). - 2010. - Т. 25, № 2, вып. 1. - С. 95.; Руководство по кардиологии / под ред. К. Коваленко. - Киев: Морион, 2008. - 1404 с.; ACC/AHA guidelines for percutaneous coronary intervention (Revision of the 1993 PTCa guidelines) - executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) // Circulation. - 2001. - Vol. 103. -P. 3019-3041.; Antman E.M., Cohen M., Bernink P.J., McCabe C.H. et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making // JAMA. - 2000. - Vol. 284. - P. 835-842.; Bassand J.P., Hamm C.W., Ardissino D. et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes // Eur. Heart J. - 2007. - Vol. 28. - P. 1598-1660.; Berger J.S., Frye C.B., Harshaw Q. et al. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis // J. Am. Coll. Cardiol. - 2008. - Vol. 52. - P. 1693-1701.; Careaga-Reyna G., Martinez-Carballo G., Villanueva-Rustrian F. et al. Coronary artery bypass graft surgery in patients with acute coronary syndrome. Analysis of results // Circulation. - 2006. -Vol. 74, No. 5. - P. 315-320.; Chew D.P., Mahaffey K.W., White H.D. et al. Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict // Am. Heart J. - 2008. - Vol. 155, No. 5. -P. 841-847.; Collet J.P., Montalescot G., Blanchet B. et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes // Circulation. - 2004. - Vol. 110. -P. 2361-2367.; Christiansen S., Autschbach R. Results and treatment strategy for patients undergoing emergent coronary artery bypass grafting // Ann. Thorac. Cardiovasc. Surg. - 2010. - Vol. 16, No. 3. - P. 168-173.; Chaudhary A., Pande S., Agarwal S.K. et al. OPCAB in acute coronary syndrome: predictors of intra-aortic balloon pump use // Indian Heart J. - 2009. - Vol. 61, No. 3. - P. 249-253.; Chen Y., Almeida A.A., Goldstein J. et al. Urgent and emergency coronary artery bypass grafting for acute coronary syndromes // ANZ J. Surg. - 2006. - Vol. 76, No. 9. - P. 769-773.; Deyell M.W., Ghali W.A., Ross D.B. et al. Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Timing of nonemergent coronary artery bypass grafting and mortality after non-ST elevation acute coronary syndrome // Am. Heart J. - 2010. - Vol. 159, No. 3. -P. 490-496.; Fitchett D., Eikelboom J., Fremes S. et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society // Can. J. Cardiol. - 2009. - Vol. 25. - P. 683-689.; Fox K.A., Mehta S.R., Peters R. et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial // Circulation. - 2004. - Vol. 110. - P. 1202-1208.; Fox K.A., Dabbous O.H., Goldberg R.J. et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) // BMJ. - 2006. -P. 1091-1094.; Fukui T., Shimokawa T., Manabe S., Takanashi S. Early and midterm outcome of off-pump coronary artery bypass grafting in patients with acute myocardial infarction // Kyobu Geka. - 2009. - Vol. 62, No. 1. - P. 36-40.; Giugliano R.P., White J.A., Bode C. et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes // N. Engl. J. Med. - 2009. - Vol. 360. - P. 2176-2190.; Grines C.L., Bonow R.O., Casey D.E. Jr. et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians // Circulation. - 2007. - Vol. 115. - P. 813-818.; Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European. Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) // Eur. Heart J. - 2010. - Vol. 31. -P. 2501-2555.; Held C., Asenblad N., Bassand J.P. et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery results from the PLATO (Platelet Inhibition and Patient Outcomes) Trial // J. Am. Coll. Cardiol. - 2011. - Vol. 57. - P. 672-684.; Ho P.M., Peterson E.D., Wang L. et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome // JAMA. - 2008. -Vol. 299. - P. 532-539.; Jones H.U., Muhlestein J.B., Jones K.W. et al. Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome clinical investigation and reports // Circulation. - 2002. - Vol. 106. - P. I-19-I-22.; Kapetanakis E.I., Medlam D.A., Boyce S.W. et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist’s panacea or the surgeon’s headache? // Eur. Heart J. - 2005. - Vol. 26. - P. 576-583.; Kaya K., Cavolli R., Telli A. et al. Off-pump versus on-pump coronary artery bypass grafting in acute coronary syndrome: a clinical analysis [Электронный ресурс] // J. Cardiothorac. Surg. - 2010. - URL: http://www.cardiothoracicsurgery.org/content/5/1/31 (дата обращения: 11.11.2014).; Keller T., Zeller T., Peetz D. et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction // N. Engl. J. Med. - 2009. - Vol. 361. - P. 868-877.; Mehta R.H., Roe M.T., Mulgund J. et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery // J. Am. Coll. Cardiol. - 2006. - Vol. 48. - P. 281-286.; Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study. Fragmin and fast revascularisation during instability in coronary artery disease investigators // Lancet. -1999. - Р. 708-715.; Monteiro P. Portuguese Registry on Acute Coronary Syndromes. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population // Circulation. -2006. - Vol. 114, suppl. 1. - P. 467-472.; Paparella D., Scrascia G., Paramythiotis A. et al. Preoperative cardiac troponin I to assess midterm risks of coronary bypass grafting operations in patients with recent myocardial infarction // Ann. Thorac. Surg. - 2010. - Vol. 89, No. 3. - P. 696-702.; Parikh S.V., de Lemos J.A., Jessen M.E. et al. Crusade and action Registry-GWTG Participants. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines) // JACC Cardiovasc. Interv. - 2010. - Vol. 3. - P. 419-427.; Sezai A., Hata M., Wakui S. et al. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome // Circulat. J. - 2007. - Vol. 71, No. 9. - P. 1401-1407.; Song S.W., Youn Y.N., Yi G. et al. Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome // Circulat. J. - 2008. - Vol. 72, No. 4. - P. 626-632.; Takai H., Kobayashi J., Tagusari O. et al. Off-pump coronary artery bypass grafting for acute myocardial infarction // Circulat. J. -2006. - Vol. 70, No. 10. - P. 1303-1306.; Thielmann M., Massoudy P., Neuhäuser M. et al. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes // Circulation. - 2006. - Vol. 114, No. 1, suppl. - P. 448-453.; Weiss E.S., Chang D.D., Joyce D.L. et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data // J. Thorac. Cardiovasc. Surg. - 2008. - Vol. 135. - P. 503-511.; Yan A.T., Yan R.T., Tan M. et al. Inhospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score // Am. J. Cardiol. - 2005. -Vol. 96. - P. 913-916.; https://www.sibjcem.ru/jour/article/view/93

  5. 5
    Academic Journal
  6. 6
  7. 7
    Academic Journal

    مصطلحات موضوعية: ПРОФЕССИОНАЛЬНОЕ ОБЩЕНИЕ,PROFESSIONAL COMMUNICATION,ДЕЛОВОЕ ОБЩЕНИЕ,BUSINESS COMMUNICATION,ИНОСТРАННЫЙ ЯЗЫК,FOREIGN LANGUAGE,ОБРАЗОВАТЕЛЬНЫЙ РЕЗУЛЬТАТ,EDUCATIONAL RESULT,СТРАТЕГИЯ ВЕДЕНИЯ "SMALLTALK",STRATEGY OF HAVING "SMALLTALK",МАЛЕНЬКАЯ БЕСЕДА,SMALL TALK

    وصف الملف: text/html

  8. 8
  9. 9
  10. 10
  11. 11
    Academic Journal
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    المصدر: Вестник МГИМО Университета.

    مصطلحات موضوعية: АНТИГИТЛЕРОВСКАЯ КОАЛИЦИЯ, СТРАТЕГИЯ ВЕДЕНИЯ ВОЙНЫ В ЗАПАДНОЙ ЕВРОПЕ, ПРОБЛЕМА ОТКРЫТИЯ ВТОРОГО ФРОНТА, "БОЛЬШАЯ ТРОЙКА", СТАЛИН, ЧЕРЧИЛЛЬ, РУЗВЕЛЬТ, ОПЕРАЦИЯ "ОВЕРЛОРД", АРДЕННСКИЙ ПРОРЫВ, ВКЛАД ВТОРОГО ФРОНТА В ЗАВЕРШЕНИЕ РАЗГРОМА ВЕРМАХТА

    وصف الملف: text/html

  19. 19
  20. 20